[go: up one dir, main page]

MA41812A - Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc - Google Patents

Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc

Info

Publication number
MA41812A
MA41812A MA041812A MA41812A MA41812A MA 41812 A MA41812 A MA 41812A MA 041812 A MA041812 A MA 041812A MA 41812 A MA41812 A MA 41812A MA 41812 A MA41812 A MA 41812A
Authority
MA
Morocco
Prior art keywords
intermediaries
hcv
preparation
methods
protease inhibitor
Prior art date
Application number
MA041812A
Other languages
English (en)
Inventor
Maude Brossat
Dominique Paul Michel Depré
Sébastien Nicolas J Hermant
Andras Horvath
Sébastien François Emmanuel LEMAIRE
Thomas Shaw Moody
Dominic John Ormerod
Olivier Riant
Nicolas Vriamont
Original Assignee
Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc
Publication of MA41812A publication Critical patent/MA41812A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/82Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/001Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26Ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/60Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/61Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MA041812A 2015-03-27 2016-03-24 Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc MA41812A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15161431 2015-03-27

Publications (1)

Publication Number Publication Date
MA41812A true MA41812A (fr) 2018-01-30

Family

ID=52737010

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041812A MA41812A (fr) 2015-03-27 2016-03-24 Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc

Country Status (15)

Country Link
US (1) US20180093943A1 (fr)
EP (1) EP3274324A1 (fr)
JP (1) JP2018517661A (fr)
KR (1) KR20170131449A (fr)
CN (1) CN107429270A (fr)
AU (1) AU2016241924A1 (fr)
BR (1) BR112017019898A2 (fr)
CA (1) CA2976175A1 (fr)
EA (1) EA201792114A1 (fr)
HK (1) HK1247246A1 (fr)
IL (1) IL253899A0 (fr)
MA (1) MA41812A (fr)
MX (1) MX2017012348A (fr)
SG (1) SG11201707594SA (fr)
WO (1) WO2016157058A1 (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2768B1 (en) * 2005-07-29 2014-03-15 تيبوتيك فارماسيوتيكالز ليمتد Large cyclic inhibitors of hepatitis C virus
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
AU2008209697B2 (en) 2007-02-01 2014-02-20 Janssen Sciences Ireland Uc Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
CN102046622A (zh) 2008-04-15 2011-05-04 因特蒙公司 丙型肝炎病毒复制的新颖大环抑制剂
EP2382198B1 (fr) 2008-12-23 2013-07-10 Janssen Pharmaceuticals, Inc. Procédés et intermédiaires pour préparer un inhibiteur macrocyclique de protéase du vhc
MX2012010678A (es) * 2010-03-16 2012-10-15 Janssen Pharmaceuticals Inc Procedimientos e intermediarios para preparar un inhibidor macrociclico de proteasa del virus de la hepatitis c.
MX2014002171A (es) * 2011-08-24 2014-04-25 Glaxosmithkline Llc Tratamientos de combinacion para hepatitis c.
EA201490675A1 (ru) 2011-09-22 2014-08-29 Янссен Фармасьютикалз, Инк. Способы и промежуточные соединения для получения макроциклического ингибитора протеазы hcv
US8981082B2 (en) 2011-10-28 2015-03-17 Janssen Pharmaceuticals, Inc. Process for preparing an intermediate of the macrocyclic protease inhibitor TMC 435

Also Published As

Publication number Publication date
HK1247246A1 (zh) 2018-09-21
MX2017012348A (es) 2017-12-14
JP2018517661A (ja) 2018-07-05
CA2976175A1 (fr) 2016-10-06
SG11201707594SA (en) 2017-10-30
CN107429270A (zh) 2017-12-01
AU2016241924A1 (en) 2017-08-24
WO2016157058A1 (fr) 2016-10-06
EA201792114A1 (ru) 2018-01-31
EP3274324A1 (fr) 2018-01-31
IL253899A0 (en) 2017-10-31
BR112017019898A2 (pt) 2018-06-12
US20180093943A1 (en) 2018-04-05
KR20170131449A (ko) 2017-11-29

Similar Documents

Publication Publication Date Title
EP3507379A4 (fr) Procédés d'amplification numérique du génome entier
MA44884A (fr) Dispositifs et procédés de thrombectomie de l'artère carotide interne
PT3788047T (pt) Formas sólidas de um inibidor de fgfr e processos para a sua preparação
HUE053081T2 (hu) Módszerek kardiovaszkuláris események megelõzésére megmaradó kockázatú diszlipidémiás populációkban
EP3432926A4 (fr) Procédés de réduction de la toxicité d'un médicament chimiothérapeutique
EP3359693A4 (fr) Procédés et compositions pour enrichissement de produits d'amplification
EP3352774A4 (fr) Compositions de flavonoïdes et procédés d'utilisation
MA46315A (fr) Polythérapies pour malignités hématologiques avec des anticorps anti-cd38 et des inhibiteurs de la survivine
EP3303413A4 (fr) Procédés de préparation de sugammadex et de ses intermédiaires
MA45688A (fr) Compositions et procédés de potentialisation d'agents antimicrobiens
EP2791342A4 (fr) Microorganismes modifiés et procédés de fabrication du butadiène à l'aide de ceux-ci
EP2943072A4 (fr) Procédés et compositions pour modifier le profil de saveur et d'arôme de consommables
EP3443094A4 (fr) Procédés de réduction de l'expression de c9orf72
EP3289064A4 (fr) Compositions et procédés pour la détection d'allergènes
IL281015A (en) Methods and preparations for plant modification
EP3328429A4 (fr) Peptides et anticorps pour l'élimination de biofilms
IL253999B (en) History of tetrahydrothiazepine in cyclics used to treat neoplastic and/or infectious diseases
EP2967531A4 (fr) Procédés et dispositifs pour la prévention des infections du site opératoire d'incision
EP3319653A4 (fr) Procédés de préparation d'hydrogels et d'échafaudages ecm provenant du côlon
EP3423091A4 (fr) Compositions et procédés pour induire des anticorps du vih-1
EP2959292A4 (fr) Procédés et compositions pour l'évaluation de greffons de poumon
IL288830A (en) Methods for purifying an antibody and its preparations
EP3314025A4 (fr) Mutagenèse d'apobec3b et immunothérapie
EP3443105A4 (fr) Plantes de cannabis améliorées et procédés pour les produire et l'utiliser
SG10201605869QA (en) Methods For Purification Of A Virus Produced In Vitro And Clearance Assay For The Virus